- Article
- Open access
- Published:
Scientific Reports (2026) Cite this article
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.
Abstract
In this study, a novel gelatin-based wound dressing containing calcium carbonate (CaCO₃) nanoparticles loaded with gentamicin and curcumin was developed and evaluated for its physicochemical, biomechanical, biological, and antimicrobial properties. The dressing exhibited a porous sponge-like structure with interconnected pores, high hydrophilicity with a water contact angle of 15.2°, and adequate mechanical strength, with tensile strength values of 0.096 ± 0.05 MPa in the dry state and 0.083 ± 0.04 MPa after hydration. The scaffold showed progressive biodegradation, reaching approximately 90% degradation by day 10 and nearly complete degradation within 14 days. It also demonstrated excellent blood absorption capacity, absorbing nearly 35–40 times its own weight in blood. In vitro biological evaluation showed no cytotoxicity toward human dermal fibroblasts and negligible hemolytic activity (0.189 ± 0.010%). In addition, the dressing exhibited antibacterial activity against Staphylococcus aureus, with an inhibition zone diameter of 15.74 ± 1.15 mm, a minimum inhibitory concentration (MIC) of 106.33 ± 0.89 µg/mL, and a minimum bactericidal concentration (MBC) of 215.23 ± 1.5 µg/mL. Furthermore, the dressing significantly enhanced early osteogenic differentiation of mesenchymal stem cells, as evidenced by increased alkaline phosphatase activity after 14 days (p < 0.05). These findings suggest that the fabricated multifunctional dressing is a promising candidate for infected wound healing applications and may provide supportive properties for bone-related tissue regeneration, particularly in osteomyelitis management.
Subjects
Acknowledgements
The authors would like to thank the National Institute for Medical Research Development (NIMAD) for financial support of this study (grant number: 4021347).
Funding
National Institute for Medical Research Development (NIMAD) supported financials of this study (grant number: 4021347).
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics declarations
A donor of blood sample provided written informed consent prior to blood collection, and the study protocol was approved by the Ethics Committee of Tabriz University of Medical Sciences, Tabriz, Iran under the reference number IR.TBZMED.REC.1402.854.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Reprints and permissions
About this article
Cite this article
Maleki Dizaj, S., Sharifi, S., Memar, M.Y. et al. A biocompatible hemostatic and antibacterial gelatin-based wound dressing containing calcium carbonate nanoparticles loaded with gentamicin and curcumin. Sci Rep (2026). https://doi.org/10.1038/s41598-026-65723-x
Download citation
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-65723-x